ArticleFrontiers in medicine2025
Triglyceride-glucose index as a prognostic marker of endovascular thrombectomy in patients with ischemic stroke: a retrospective study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Admission Inflammatory-Metabolic Biomarker Profiles and Outcome-Specific Prognostic Patterns After Endovascular Therapy for Acute Ischemic Stroke: A Multicenter Cohort Study.Journal of inflammation research · 2026Article
- Deciphering the Underlying Mechanisms Linking Psoriasis and IgA Nephropathy.Journal of immunology research · 2026Review
- Combined effect of body mass index and atherogenic index of plasma on risk of stroke among individuals with abnormal glucose metabolism: Evidence from the China health and retirement longitudinal study.Diabetes & vascular disease researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigates the association between the triglyceride-glucose (TyG) index, a surrogate marker for insulin resistance, and clinical outcomes in patients with acute ischemic stroke (AIS) after endovascular thrombectomy (EVT). Methods: This retrospective study included 179 patients with AIS who underwent EVT. The TyG index was calculated as ln[triglycerides (TGs) (mg/dL) × glucose (mg/dL)/2] from admission blood samples. The primary outcome was functional status at 90 days post-stroke, assessed by the modified Rankin Scale (mRS). A multivariate logistic regression analysis was performed to evaluate the association between the TyG index and outcomes after adjusting for potential confounders. Results: Among the 179 patients, 77 (43.0%) had favorable outcomes (mRS ≤ 2) and 102 (57.0%) had poor outcomes (mRS > 2) at 90 days post-stroke. The TyG index was significantly higher in the poor outcome group compared to the favorable outcome group. The receiver operating characteristic curve analysis showed that the TyG index (area under the ROC curve, AUC = 0.714) had superior predictive value compared with either glucose (AUC = 0.618) or TGs (AUC = 0.574) alone or their combination (AUC = 0.633). The optimal cut-off value for the TyG index was 8.795, with a sensitivity of 0.569 and a specificity of 0.753. A multivariate logistic regression analysis confirmed that the TyG index was independently associated with poor outcomes after adjusting for conventional prognostic factors. Adding the TyG index to a prediction model significantly improved its performance (AUC from 0.776 to 0.826, Conclusion: Elevated TyG index is independently associated with poor outcomes in patients with AIS after EVT. The TyG index demonstrates superior predictive performance compared to individual metabolic parameters and significantly improves outcome prediction when added to conventional prognostic factors. These findings suggest that the TyG index may serve as a valuable prognostic marker for risk stratification in patients with AIS undergoing EVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.